VESANOID Trademark

Trademark Overview

On Tuesday, December 23, 2014, a trademark application was filed for VESANOID with the United States Patent and Trademark Office. The USPTO has given the VESANOID trademark a serial number of 79162492. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 29, 2022. This trademark is owned by Cheplapharm Arzneimittel GmbH. The VESANOID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, anti-cancer preparations
vesanoid

General Information

Serial Number79162492
Word MarkVESANOID
Filing DateTuesday, December 23, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 29, 2022
Registration Number4883622
Registration DateTuesday, January 12, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Description of MarkThe mark consists of the stylized wording "VESANOID".
Goods and ServicesPharmaceutical products, namely, anti-cancer preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCheplapharm Arzneimittel GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameCheplapharm Arzneimittel GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameCheplapharm Arzneimittel GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Saturday, June 24, 2023INTERNATIONAL REGISTRATION RENEWED
Wednesday, March 29, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 29, 2022CANCELLED SECTION 71
Tuesday, January 12, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, January 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 18, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 18, 2016FINAL DISPOSITION PROCESSED
Tuesday, April 12, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 22, 2015ASSIGNED TO LIE
Wednesday, September 9, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 9, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 26, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 26, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 2, 2015REFUSAL PROCESSED BY IB
Monday, April 13, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 13, 2015REFUSAL PROCESSED BY MPU
Friday, April 10, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 9, 2015NON-FINAL ACTION WRITTEN
Tuesday, April 7, 2015APPLICATION FILING RECEIPT MAILED
Saturday, April 4, 2015ASSIGNED TO EXAMINER
Friday, April 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 3, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 26, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

vesanoid cancer preparations anti namely products pharmaceutical